I am back with Timothee Olivier from Geneva Switzerland to discuss Part 2 of our laboratory work.  Can oncologists criticize RCTs?  We also announce our new series.  A 9 week Malignant Bookclub

4.43 - VKPrasad Lab Update Part 2 With Timothee Olivier

A podcast on medicine, oncology, & health policy. 
Host: Vinay Prasad, MD MPH from University of California San Francisco.
Tweet your feedback to @Plenary_Session or e-mail plenarysessionpodcast@gmail.com

Science & Medicine

Natural Sciences

Social Sciences

Medicine

Patient advocates, Pharma funding, and is MRD a suitable endpoint

Patient advocates funded by Pharma

FDA makes MRD the basis for AA

Another flawed quality metric. Reviewing the NEJM paper "Beta-Blockers After Myocardial Infarction and Preserved Ejection Fraction".

Beta Blockers After Heart Attacks Don't Work

Blood based and Stool DNA colon cancer screening - Two NEJM papers

Another flawed study Keynote 564. Pembro in adjuvant RCC

4.43 - VKPrasad Lab Update Part 2 With Timothee Olivier

Download our free app to listen on your phone